| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030964 |
| Receipt No. | R000035318 |
| Scientific Title | Carbon-ion radiotherapy for patients with renal cell carcinoma |
| Date of disclosure of the study information | 2018/01/25 |
| Last modified on | 2022/02/03 (Ver. 5) |
| Basic information | ||
| Public title | Carbon-ion radiotherapy for patients with renal cell carcinoma
|
|
| Acronym | Carbon-ion radiotherapy for patients with renal cell carcinoma
|
|
| Scientific Title | Carbon-ion radiotherapy for patients with renal cell carcinoma
|
|
| Scientific Title:Acronym | Carbon-ion radiotherapy for patients with renal cell carcinoma
|
|
| Region |
|
|
| Condition | ||
| Condition | Renal cell carcinoma
|
|
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety and efficacy of carbon-ion radiotherapy for renal cell carcinoma. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | safety |
| Key secondary outcomes | efficacy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | expanded access |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 16 or 12 fractionated carbon ion radiotherapy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with renal cell carcinoma
refusal of surgery or inoperable cases |
|||
| Key exclusion criteria | Patients treated with carbon ion radiotherapy | |||
| Target sample size | 27 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology | ||||||
| Division name | Hospital | ||||||
| Zip code | 263-8555 | ||||||
| Address | 4-9-1 Anagawa, Inage Ward, Chiba-City, 263-8555 Japan. | ||||||
| TEL | 043-206-3306 | ||||||
| kasuya.goro@qst.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hospital of the National Institute of Radiological Sciences | ||||||
| Division name | Hospital | ||||||
| Zip code | 2638555 | ||||||
| Address | 4-9-1 Anagawa, Inage Ward, Chiba-City, 263-8555 Japan. | ||||||
| TEL | 043-206-3306 | ||||||
| Homepage URL | |||||||
| kasuya.goro@qst.go.jp | |||||||
| Sponsor | |
| Institute | Hospital of the National Institute of Radiological Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Reliability Assurance / Audit Office |
| Address | 4-9-1 Anagawa, Inage Ward, Chiba-City, 263-8555 Japan. |
| Tel | 043-206-4706 |
| helsinki@qst.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 27 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035318 |